Data-Driven Risk Stratification for CSCC

riSCC is a clinician-focused mobile and web app designed for precise risk stratification of cutaneous squamous cell carcinoma (CSCC) in clinical settings. Built from a multinational study of over 20,000 tumors, it analyzes patient and tumor characteristics to generate an evidence-based risk score for predicting CSCC recurrence. With seamless, data-driven insights, riSCC integrates into clinical workflows, helping clinicians make informed decisions.